Consensus Keymed Biosciences Inc.

Equities

2162

KYG5252B1023

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-16 am EDT			5-day change	1st Jan Change
30.15 ^HKD	-2.11%		-7.66%	-38.59%

Apr. 12	Keymed Biosciences Advances Solid Tumors Drug With First Patient Study	MT
Mar. 27	KeyMed Biosciences’ Attributable Loss Widens in 2023	MT

Evolution of the average Target Price on Keymed Biosciences Inc.

Price target over the last 5 years

History of analyst recommendation changes

8916de31ee4ba50c693f890922.uZ2xEavL6Vnc0RP6FObxBbM6CHUpNFkpziVy_KrAwJg.4fLYXPu_rB6R4kGLRd6dXYZ4Oh9TRyB-pFdfst2rlqHm38d4-I-nLrimQg~81516f4318c3991b0e2cca969d4c55f5

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

28.48 CNY

Average target price

54.48 CNY

Spread / Average Target

+91.30%

High Price Target

63.14 CNY

Spread / Highest target

+121.73%

Low Price Target

48.74 CNY

Spread / Lowest Target

+71.16%

Consensus detail

Consensus revision (last 18 months)

Ratings for Keymed Biosciences Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar